Shares of Dr. Martens plc (LON:DOCS - Get Free Report) were up 25.8% during trading on Friday . The company traded as high as GBX 76 ($1.03) and last traded at GBX 75.40 ($1.02). Approximately 8,364,149 shares were traded during mid-day trading, an increase of 271% from the average daily volume of 2,253,765 shares. The stock had previously closed at GBX 59.95 ($0.81).
Analysts Set New Price Targets
Separately, Royal Bank of Canada cut their price target on shares of Dr. Martens from GBX 7,000 ($95.06) to GBX 6,000 ($81.48) and set a "sector perform" rating for the company in a report on Monday, May 19th.
Read Our Latest Research Report on DOCS
Dr. Martens Price Performance
The stock's fifty day moving average price is GBX 54.73 and its 200-day moving average price is GBX 62.64. The firm has a market cap of £786.32 million, a price-to-earnings ratio of 11.48, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27.
Dr. Martens (LON:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. As a group, equities research analysts forecast that Dr. Martens plc will post 2.5809394 earnings per share for the current fiscal year.
Dr. Martens Cuts Dividend
The company also recently declared a dividend, which was paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th were issued a dividend of GBX 0.85 ($0.01) per share. The ex-dividend date of this dividend was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens's dividend payout ratio is currently 42.53%.
Insider Buying and Selling
In other news, insider Giles Wilson bought 32,640 shares of the stock in a transaction that occurred on Tuesday, March 25th. The stock was bought at an average cost of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,934.82). In the last quarter, insiders purchased 33,206 shares of company stock valued at $1,792,771. Company insiders own 4.36% of the company's stock.
About Dr. Martens
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
